Results 241 to 250 of about 27,710,413 (387)

Developing in vitro expanded CD45RA+regulatory T cells as an adoptive cell therapy for Crohn's disease [PDF]

open access: hybrid, 2015
James B. Canavan   +20 more
openalex   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

open access: yesMolecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici   +8 more
wiley   +1 more source

CAR-T cells immunotherapy in the treatment of glioblastoma. [PDF]

open access: yesCancer Immunol Immunother
Królikowska A, Tarnowski M.
europepmc   +1 more source

MBNL loss facilitates resistance to T cell infiltration in vivo.

open access: green
Austin M. Gabel (15162431)   +7 more
openalex   +1 more source

NAD+ Released during Inflammation Participates in T Cell Homeostasis by Inducing ART2-Mediated Death of Naive T Cells In Vivo [PDF]

open access: bronze, 2007
Sahil Adriouch   +5 more
openalex   +1 more source

CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.

open access: yesJournal of Clinical Investigation, 2016
C. Turtle   +22 more
semanticscholar   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

Image 3_Urokinase-type plasminogen activator deficiency enhances CD8+ T cell infiltration and anti-PD-1 therapy efficacy in prostate cancer.tif

open access: green
Xiaoyi Li (669720)   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy